Literature DB >> 6116042

Association of postoperative delirium with raised serum levels of anticholinergic drugs.

L E Tune, N F Damlouji, A Holland, T J Gardner, M F Folstein, J T Coyle.   

Abstract

Drugs with anticholinegic effects are often used in surgical procedures and may impair higher cognitive functions and produce delirious states. This prospective study examined the relation between serum levels of anticholinergic drugs, measured by a radioreceptor assay, and the development of delirium in patients undergoing cardiac surgery. Most patients who had postoperative delirium had high serum levels of anticholinergic drugs, whereas those who remained cognitively intact had low levels; and impairment in cortical function correlated with serum levels of anticholinergic drugs (p less than 0.001). Raised serum levels of drugs with anticholinergic effects may contribute to the development of delirium, and to the increase in risk of morbidity following cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116042     DOI: 10.1016/s0140-6736(81)90994-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

2.  Comparison of perioperative mental function after general anaesthesia and spinal anaesthesia with intravenous sedation.

Authors:  F F Chung; A Chung; R H Meier; E Lautenschlaeger; C Seyone
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

Review 3.  Delirium in hospitalized elderly.

Authors:  J Francis; W N Kapoor
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

Review 4.  Drug-induced delirium. Incidence, management and prevention.

Authors:  G L Carter; A H Dawson; R Lopert
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

5.  Central Anticholinergic Adverse Effects and Their Measurement.

Authors:  Pasi Lampela; Teemu Paajanen; Sirpa Hartikainen; Risto Huupponen
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

6.  Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.

Authors:  Gloria Brombo; Lara Bianchi; Elisa Maietti; Francesca Malacarne; Andrea Corsonello; Antonio Cherubini; Carmelinda Ruggiero; Graziano Onder; Stefano Volpato
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

7.  Approaches to Optimize Medication Data Analysis in Clinical Cohort Studies.

Authors:  Matthew S Duprey; John W Devlin; Becky A Briesacher; Thomas G Travison; John L Griffith; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2020-10-01       Impact factor: 5.562

8.  Toxic coma induced by anticholinergic eye drops.

Authors:  J Nadal; V De la Fuente; M Abadias; J Torrent; F Jané
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-21

9.  Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.

Authors:  Pasi Lampela; Piia Lavikainen; J Arturo Garcia-Horsman; J Simon Bell; Risto Huupponen; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

Review 10.  The cognitive impact of anticholinergics: a clinical review.

Authors:  Noll Campbell; Malaz Boustani; Tony Limbil; Carol Ott; Chris Fox; Ian Maidment; Cathy C Schubert; Stephanie Munger; Donna Fick; David Miller; Rajesh Gulati
Journal:  Clin Interv Aging       Date:  2009-06-09       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.